Owner Amgen Inc.

Inventors Potashman, Michelle; Albrecht, Brian K.; Hungate, Randall W.; Bellon, Steven; Booker, Shon; Yang, Kevin; Lewis, Richard T.; Peterson, Emily A.; Kim, Tae-seong; Siegmund, Aaron C.; Hirai, Satoko; Liu, Longbin; Bauer, David; Springer, Stephanie; Harmange, Jean-christophe; Copeland, Katrina W.; Norman, Mark H.; Bode, Christiane M.; D'Amico, Erin; Choquette, Deborah; Stec, Markian; Romero, Karina; Xi, Ning; Boezio, Alessandro; Lohman, Julia

Agent Shelston IP

Pub. Number AU-A-2008348182

PCT Pub. Number WO2009/091374

Priority 12/009,123 15.01.08 US

Filing date 14 October 2008

Wipo publication date 23 July 2009

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4355 (2006.01)

A61K 31/4365 (2006.01)

A61K 31/437 (2006.01)

A61K 31/4375 (2006.01)

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms